Darren Groom

All the posts published.
NetScientific plc ("NetScientific" or the "Company")   Grant of Options to Director London, UK – 25 September 2020 – NetScientific plc (AIM:NSCI) (the "Company"), the…
NetScientific plc (“NetScientific” or the “Company” or the “Group”) Interim Results for the six months ended 30 June 2020   London, UK…
TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer…
TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer…
NetScientific plc ("NetScientific" or the "Company")   Result of General Meeting NetScientific plc (AIM:NSCI), the transatlantic healthcare IP commercialisation group, is pleased to…
TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer…
NetScientific plc ("NetScientific" or the "Company")    Issue of Equity NetScientific plc (AIM:NSCI), the transatlantic healthcare IP commercialisation group, announces that to…
NetScientific plc ("NetScientific" or the "Company") PDS Biotechnology Corporation Announces Closing of Approx. $19 Million Public Offering and Full Exercise of Underwriter's…
NetScientific plc ("NetScientific" or the "Company") Sofant Technologies Ltd secures £2.3m in an oversubscribed funding round led by EMV Capital NetScientific plc…
NetScientific plc ("NetScientific" or the "Company") PDS Biotechnology Corporation Announces Pricing of $16.5 Million Public Offering of Common Stock NetScientific plc (AIM:NSCI),…
NetScientific plc ("NetScientific" or the "Company") PDS Biotechnology Corporation Announces Proposed Public Offering of Common Stock NetScientific plc (AIM:NSCI), the transatlantic healthcare…
NetScientific plc ("NetScientific" or the "Company")   Posting of shareholder circular   Further to its announcement of 5 August 2020, NetScientific plc (AIM:NSCI),…
TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer…
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART,…
THE INFORMATION IN THIS ANNOUNCEMENT, WHICH INCLUDES CERTAIN INFORMATION DRAWN FROM PUBLIC SOURCES, DOES NOT PURPORT TO BE COMPREHENSIVE AND HAS NOT…
NetScientific plc ("NetScientific" or the "Company") PDS Biotechnology Announces Preclinical Data for PDS0203, a T-Cell Activating Recombinant Protein Vaccine Against COVID-19 Versamune-CoV-2…
NetScientific plc (“NetScientific” or the “Company”) PDS Biotech Collaborator Granted NIAID Award to Accelerate Development of Versamune®-Based Universal Influenza Vaccine   London,…
NetScientific plc (“NetScientific” or the “Company”) G – Tech Medical, Inc. (“G – Tech”) announces completion of $6.7m Series A financing round…
TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer…
TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer…
NetScientific plc (“NetScientific” or the “Company”) Result of 2020 Annual General Meeting     London, UK – 24th June 2020 – NetScientific plc…
NetScientific plc (“NetScientific” or the “Company”) PDS Biotechnology and Farmacore Biotechnology Announce Co-Development of PDS0204 COVID-19 Vaccine   London, UK – 18…
NetScientific plc (“NetScientific” or the “Company”) PDS Biotech Announces initiation of Phase 2 Trial of PDS0101 Led by the National Cancer Institute…
NetScientific plc (“NetScientific” or the “Company”) PDS Biotech Announces Clinical Trial of Its Lead Immunotherapy Product, PDS0101, in Combination with Chemoradiotherapy in…
  NetScientific plc (“NetScientific” or the “Company”) Notice of AGM     London, UK – 1 June 2020 – NetScientific plc (AIM:…
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 NetScientific plc (“NetScientific” or the “Company”) PDS…
NetScientific plc (“NetScientific” or the “Company”) Confirmation of Board Changes London, UK – 1 May 2020 – NetScientific plc (AIM: NSCI), the…
NetScientific plc (“NetScientific” or the “Company”) PDS Biotechnology Expands CRADA with the National Cancer Institute to Include Second Versamune®-Based Anti-Cancer Product  …
NetScientific plc   ("NetScientific" or the "Group")   NetScientific Full Year Preliminary Results for the year ended 31 December 2019   London,…
NetScientific plc (“NetScientific” or the “Company”) PDS Biotechnology Initiates Novel Vaccine Development Programs For COVID-19 and Universal Influenza; Delay of PDS0101 VERSATILE-002…
NetScientific plc (“NetScientific” or the “Company”) PDS Biotechnology Appoints Dr. Ilian Iliev to Board of Directors   London, UK – 14 April…
NetScientific plc (“NetScientific” or the “Company”) Board Changes London, UK – 31 March 2020 – NetScientific plc (AIM: NSCI), the transatlantic healthcare…
TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer…
TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS   1a. Identity of the issuer or the underlying…
NetScientific plc (“NetScientific” or the “Company”) PDS Biotechnology equity issue and related party transaction   London, UK – 12 February 2020: NetScientific plc…
NetScientific plc (“NetScientific” or the “Company”) PDS Biotechnology proposed offering   London, UK – 11 February 2020:  NetScientific plc (AIM: NSCI), the…
NetScientific plc (“NetScientific” or the “Company”) Board Change Resignation of Ian Postlethwaite as CEO, CFO and Company Secretary London, UK – 15…
TR-1: Standard form for notification of major holdings    NOTIFICATION OF MAJOR HOLDINGS   1a. Identity of the issuer or the underlying…
NetScientific plc (“NetScientific” or the “Company”) Board Changes London, UK – 13 December 2019 – NetScientific plc (AIM: NSCI), the transatlantic healthcare…
NetScientific plc (“NetScientific” or the “Company”)   Portfolio Company Glycotest Inc. receives the second  $3 million tranche of the $10 million Series…
NetScientific plc (“NetScientific” or the “Company”) Appointment to the Board   London, UK – 14 October 2019 – NetScientific plc (AIM: NSCI),…
NetScientific plc (“NetScientific” or the “Company”)   Portfolio Company PDS Biotechnology collaborates with Merck in Phase 2 studies for PDS0101 in metastatic…
NetScientific plc (“NetScientific” or the “Company”) Portfolio Company PDS Biotechnology to prioritise lead immunotherapy treatment in high-risk human papillomavirus (HPV) into Phase…
NetScientific plc (“NetScientific” or the “Company”) Portfolio Company PDS Biotechnology announces new positive data for lead immunotherapy treatment in high-risk human papillomavirus…
NetScientific plc (“NetScientific” or the “Company” or the “Group”) Interim Results for the six months ended 30 June 2019   Portfolio companies…
1 August 2019 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 NetScientific plc (“NetScientific” or…
31 July 2019 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 NetScientific plc (“NetScientific” or…
TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS   1a. Identity of the issuer or the underlying…
TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS    1a. Identity of the issuer or the underlying…
NetScientific plc (“NetScientific” or the “Company”) Result of Annual General Meeting     London, UK – 18th June 2019 – NetScientific plc…
NetScientific plc ("NetScientific" or the "Group") New data demonstrates NEATstik’s potential as a rapid bacterial monitoring tool in lung disease   Published…
NetScientific plc (“NetScientific” or the “Company” or the “Group”)     Notice of AGM and Annual Report & Accounts   London, UK…
NetScientific plc   ("NetScientific" or the "Group")   NetScientific Full Year Results for the year ended 31 December 2018   London, UK…
16 May 2019 NetScientific plc ("NetScientific" or the "Company") PDS Biotechnology journal publication   NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP…
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 25 April 2019 NetScientific plc (“NetScientific” or…
22 March 2019 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014   NetScientific plc ("NetScientific"…
19 March 2019 NetScientific plc ("NetScientific" or the "Company") PDS merger with Edge Therapeutics update Further to its announcements on 26 November…
18 March 2019 NetScientific plc ("NetScientific" or the "Company") PDS completes merger with Edge Therapeutics Further to its announcement 26 November 2018,…
18 March 2019 NetScientific plc ("NetScientific" or the "Company") Orderly wind up of Wanda and Vortex   Further to its announcement and…
14 March 2019 NetScientific plc ("NetScientific" or the "Company") Share Price Movement NetScientific plc (AIM: NSCI) notes its recent share price movement…
Further to the announcement on 1 March 2019, NetScientific plc (AIM: NSCI) announces that at the general meeting held earlier today a…
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft…
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft…
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft…
Mon, 18th Feb 2019 16:54RNS Number : 4056QNetScientific PLC18 February 2019 TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR…
London, UK – February 14, 2019 – Further to its earlier related announcement on 22 October 2018, NetScientific plc (“NetScientific”, AIM: NSCI),…
Merger would create publicly-traded immuno-oncology biotechnology company developing novel products for treating early- and late-stage cancer Growing product pipeline utilising Versamune®, a…
London, UK – 08 November 2018 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation group, announces that its US-based portfolio…
London, UK – 1 November 2018 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation group, announces that its US-based portfolio…
The following amendments have been made to the ‘Glycotest Completes $10m Series A Round with Fosun’ announcement (RNS Number: 6823E) released on…
NetScientific plc (“NetScientific” or the “Company” or the “Group”)   NetScientific Interim Results for the six months ended 30 June 2018  …
- 1,000 patient BRIDGE study to be funded by the European Respiratory Society   London, UK – 20 September, 2018 – NetScientific…
London, UK – August 15, 2018 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation Group, announces that portfolio company Wanda,…
- ProteaseTag® Active Proteinase-3 Immunoassay aimed at researchers studying COPD, cystic fibrosis, and bronchiectasis   London, UK – 02 August, 2018 –…
London, UK – 2nd August 2018 – NetScientific plc ("NetScientific", AIM:NSCI), the transatlantic healthcare IP commercialisation Group, is delighted to announce the…
London, UK – July 18th, 2018 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation Group, announces that portfolio company Wanda,…
London, UK – 26th June 2018 – NetScientific plc (AIM:NSCI) (the “Company”), the transatlantic healthcare IP commercialisation Group, today announced that on…
London, UK – 21st June 2018 – NetScientific plc ("NetScientific", AIM:NSCI), the transatlantic healthcare IP commercialisation Group, announces that all resolutions proposed…
London, UK – 6th June 2018 – NetScientific plc ("NetScientific", AIM:NSCI), the transatlantic healthcare IP commercialisation Group, announces that its portfolio company…
London, UK – June 4th, 2018 – NetScientific plc (“NetScientific”, AIM: NSCI), the transatlantic healthcare IP commercialisation group, announces that its portfolio…
London, UK – June 1st, 2018 – NetScientific plc (“NetScientific”, AIM: NSCI), the transatlantic healthcare IP commercialisation group, announces that its portfolio…
London, UK – 22nd May 2018 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation group, announces that, in accordance with…
London, UK – May 21st, 2018 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation Group, announces that Wanda and Health…
London, UK – May 2nd 2018 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation group, announces an update for its…
18 April 2018 NetScientific plc   Directors Dealing Notification   NetScientific plc (AIM:NSCI) (the “Company”), the transatlantic healthcare IP commercialisation group, announces…
Data demonstrate the use of circulating tumour cells for identifying clinical biomarkers, such as EGFR mutations and PD-L1 expression, in patients with…
BioTrinity - Panel: AIM v NASDAQ v European Listing - What's best for you - London (24 April) Approaching the 12th consecutive…
NetScientific plc   ("NetScientific" or the "Group")   NetScientific Full Year Results for the year ended 31 December 2017   London, UK…
RNS Number : 7628I NetScientific PLC 21 June 2017 NetScientific plc ("NetScientific" or the "Company" or the "Group") Result of Annual General…
RNS Number : 3190I NetScientific PLC 16 June 2017 The following is to be read in replacement of the Holdings In Company…
Darren Groom, Author at NetScientific